March 11, 2025 India's Syngene International acquires first US biologics ... names Peter Bains as group CEO Indian drugmaker Biocon Ltd on Monday appointed Peter Bains as the group's chief ...

BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization ...

Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer, ...

As of March 10, Syngene International Ltd. announces its first biologics facility purchase in the USA. The site houses several monoclonal antibody (mAbs) production lines. Syngene USA Inc., a ...

Alex Del Priore, senior vice president – development & manufacturing services, Syngene International Ltd., said, “This facility is a significant milestone and comes in response to growing client ...

India's Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent Manufacturing Operations Baltimore, a unit of Emergent BioSolutions, for ...

It will also provide clients, access to collective service capability of multiple geographic sites, scientists and experience,” said Peter Bains, CEO Designate, Syngene International Ltd. The ...

Expected to enhance global innovator flexibility with biologics drug substance facility in Baltimore BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a ...